<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: therapeutic drug</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Scientists develop potential new treatment for autoimmune diseases</title>
   	 <description>Scientists at Montana State University have developed a therapeutic that has potential as a biological drug or probiotic food product to combat many of the more than 80 autoimmune disorders that affect some 23.5 million people in the United States.</description>
     <link>http://medicalxpress.com/news/2013-05-scientists-potential-treatment-autoimmune-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 17 May 2013 08:37:08 EST</pubDate>
	 <guid isPermaLink="false">news287998611</guid>
	 
</item>
<item>
     <title>Beyond Botox: Natural born killer or medical miracle?</title>
   	 <description>Botox is best known for its use in cosmetic procedures, but this potent neurotoxin could be transformed into an extraordinary drug to treat a raft of debilitating conditions, a leading scientist will tell an audience at the University of Lincoln.</description>
     <link>http://medicalxpress.com/news/2013-03-botox-natural-born-killer-medical.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 15 Mar 2013 06:43:39 EST</pubDate>
	 <guid isPermaLink="false">news282548554</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/beyondbotoxn.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers find potential new therapeutic target for treating non-small cell lung cancer</title>
   	 <description>Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response.</description>
     <link>http://medicalxpress.com/news/2013-02-moffitt-potential-therapeutic-non-small-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 15 Feb 2013 03:17:20 EST</pubDate>
	 <guid isPermaLink="false">news280120593</guid>
	 
</item>
<item>
     <title>Alzheimer's-plagued Colombia region is focus of drug trial</title>
   	 <description>The unusually high incidence of early-onset Alzheimer's disease in this isolated cattle town has thrust it to the forefront of global efforts to find a cure for the debilitating malady.</description>
     <link>http://medicalxpress.com/news/2012-12-alzheimer-plagued-colombia-region-focus-drug.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 17 Dec 2012 10:17:01 EST</pubDate>
	 <guid isPermaLink="false">news274961815</guid>
	 
</item>
<item>
     <title>TGen-US Oncology data guides treatment of metastatic triple-negative breast cancer patients</title>
   	 <description>Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen) and US Oncology Research.</description>
     <link>http://medicalxpress.com/news/2012-12-tgen-us-oncology-treatment-metastatic-triple-negative.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 06 Dec 2012 15:19:37 EST</pubDate>
	 <guid isPermaLink="false">news274029561</guid>
	 
</item>
<item>
     <title>Discovery may shed light on why some HIV-positive patients have more virus</title>
   	 <description>(Medical Xpress)—Biologists at UC San Diego have unraveled the anti-viral mechanism of a human gene that may explain why some people infected with HIV have much higher amounts of virus in their bloodstreams than others.</description>
     <link>http://medicalxpress.com/news/2012-09-discovery-hiv-positive-patients-virus.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 24 Sep 2012 07:10:48 EST</pubDate>
	 <guid isPermaLink="false">news267689428</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/3-discoverymay.jpg" width="90" height="90" />
</item>
<item>
     <title>Possible new pathway can overcome glioblastoma resistance</title>
   	 <description>Glioblastoma, a lethal brain cancer, is one of the most resistant to available therapies and patients typically live approximately 15 months.</description>
     <link>http://medicalxpress.com/news/2012-01-pathway-glioblastoma-resistance.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 24 Jan 2012 11:37:28 EST</pubDate>
	 <guid isPermaLink="false">news246627439</guid>
	 
</item>
<item>
     <title>Purdue takes prostate cancer treatment from concept to clinical trial</title>
   	 <description>(Medical Xpress) -- A clinical trial for a new technology to diagnose and treat prostate cancer marks the first time Purdue University has directed the entire pathway of a therapeutic product from early research to patient treatment.</description>
     <link>http://medicalxpress.com/news/2011-06-purdue-prostate-cancer-treatment-concept.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Jun 2011 07:02:06 EST</pubDate>
	 <guid isPermaLink="false">news226821416</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/prostatecancer-graphic.jpg" width="90" height="90" />
</item>


</channel>
</rss>
